Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9844-9856

  Chattopadhyay, D ^a   Ghosh, M K ^a   Mal, A ^a   Harter, M L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE 2; DOXORUBICIN; E1A PROTEIN; PROTEIN P21; PROTEIN P300; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA CONTENT; DNA DAMAGE; ENZYME ACTIVITY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION;

ADENOVIRUS E1A PROTEINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DNA DAMAGE; DOXORUBICIN; G1 PHASE; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034801802     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9844-9856.2001     Document Type: Article

References (85)

1. A p53-dependent S-phase checkpoint helps protect cells from DNA damage in response to starvation for pyrimidine nucleotides
2. Transcriptional activation by p53, but not induction of p21 gene, is essential for oncogene mediated apoptosis
3. Enhanced phosphorylation of p53 by ATM response to DNA damage
4. Quantitative analysis of regions of adenovirus E1A products involved in interactions with cellular proteins
5. ARF links the tumour suppressors RB and p53
6. Waf1/Cip1 expression
7. 1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase 11 blockage
8. 1 arrest after γ-irradiation
9. Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A + cHa-ras transformed cells after γ-irradiation
10. 2 arrest after DNA damage
11. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53
12. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53
13. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage
14. pRb phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F
15. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis
16. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
17. 1 checkpoint control
18. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis
19. ARF tumor suppressor
20. Primary cells suppress oncogene-dependent apoptosis
21. 1 arrest
22. 1 arrest and apoptosis
23. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
24. Oncogene-dependent apoptosis is mediated by caspase-9
25. 2 checkpoint is retinoblastoma protein dependent
26. 2-mediated apoptosis of human colorectal carcinoma cells
27. 1
28. Monoclonal antibodies specific for adenovirus early region 1A proteins: Extensive heterogeneity in early region 1A pruducts
29. pRB plays an essential role in cell cycle arrest induced by DNA damage
30. Perturbation of the p53 response by human papillomavirus type 16 E7
31. DNA damage-induced activation of p53 by the checkpoint kinase Chk2
32. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
33. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein
34. CIP1/WAF1
35. 1/S transition and S-phase progression
36. Radiation effects on DNA synthesis in a defined chromosomal replicon
37. Kip1 mediates apoptosis in endothelial cells through activation of cdk2: Role of a caspase cascade
38. Binding and modulation of p53 by p300/CBP coactivators
39. DNA topoisomerase poisons as antitumor drugs
40. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck
41. Activation of p53 by oncogenes
42. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
43. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
44. WAF1/CIP1/SDII lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma
45. Cyclin E-induced S phase without activation of the pRb/E2F pathway
46. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
47. p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells
48. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes
49. Kip1 in TGF-β treated cells
50. bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis
51. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases
52. INK4a
53. Cyclin-dependent kinases: Engines, clocks, and microprocessors
54. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication
55. Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons
56. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
57. The restriction point and control of cell proliferation
58. Genetic determinants of p53-induced apoptosis and growth arrest
59. The Ink4a tumor suppressor gene product p19ARF interacts with mdm2 and neutralises mdm2's inhibition of p53
60. Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage
61. Signaling to p53: Breaking the MDM2-p53 circuit
62. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis
63. The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19-kDa and Bcl-2 proteins
64. Bcl-2 and the ICE family of apoptotic regulators: Making a connection
65. 2 arrest in esophageal squamous cell carcinoma
66. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant
67. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins
68. Lack of correlation between p53 protein level and sensitivity to DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants
69. Apoptosis and therapy
70. Cancer cell cycles
71. 1 cyclin-dependent kinases
72. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
73. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region
74. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways
75. Waf1/Cip1 inhibition of cyclin E/cdk2 activity prevents endoreduplication after mitotic spindle disruption
76. WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis
77. Distinct roles for cyclin-dependent kinases in cell cycle control
78. 1 arrest in human cancer cells
79. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
80. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and the control of cell growth
81. Resistance to apoptosis conferred by cdk inhibitors during myocyte differentiation
82. WAF1 signalling pathway
83. ARF gene transfer in human mesothelioma cells
84. 1/S cyclin-dependent kinases
85. ARF promotes mdm2 degradation and stabilises p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways